STJ St. Jude Medical Inc.
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
- 19.31 P/E
- 3.34 P/S
- 4.56 P/B
- 3.46 EPS
- 14.54% Cash ROIC
- 0.54 Cash Ratio
- 1.08 / 1.62% Dividend
- 2.07M Avg. Vol.
- 281.28M Shares
- 18.756B Market Cap.
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab...
Minneapolis Star Tribune - Feb 27, 2015
Settlement Reached in Lawsuits And Claims Involving Riata Defibrillator Leads - Virtual-Strategy Magazine (press release)
Business Wire (press release) - Feb 27, 2015
The Legacy - Feb 28, 2015
MarketWatch - Feb 24, 2015
Wall Street Pit - Feb 24, 2015
OctaFinance.com - Feb 4, 2015
Update: St. Jude Medical, Inc. Insider Trading Disclosure - Bar and Graph Report
Ashburn Daily - 4 hours ago
Dakota Financial News - Feb 24, 2015
The Legacy - Feb 23, 2015
Dakota Financial News - Feb 26, 2015
Credit Suisse Lowers St. Jude Medical to Underperform (STJ) - Intercooler